Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
Clinical trial NCT05035095 · COMPLETED
Trial details
- NCT number
- NCT05035095
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-13
- Primary completion
- 2023-03-24
- Enrollment
- 667
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.